Smith & Nephew (LON:SN) Stock Crosses Above 200-Day Moving Average - Time to Sell?

Smith & Nephew plc (LON:SN - Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,068.92 ($13.96) and traded as high as GBX 1,127 ($14.72). Smith & Nephew shares last traded at GBX 1,120.50 ($14.63), with a volume of 2,614,359 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reaffirmed a "buy" rating and issued a £145 ($189.34) price objective on shares of Smith & Nephew in a research report on Monday, August 5th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of GBX 3,956.20 ($51.66).

Smith & Nephew Stock Up 0.6 %

The company has a market cap of £9.83 billion, a PE ratio of 4,175.93, a PEG ratio of 0.46 and a beta of 0.62. The stock's 50 day moving average price is GBX 1,156.20 and its 200-day moving average price is GBX 1,068.92. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51.

Smith & Nephew Cuts Dividend

The company also recently declared a dividend, which will be paid on Friday, November 8th. Investors of record on Thursday, October 3rd will be issued a dividend of $0.14 per share. The ex-dividend date is Thursday, October 3rd. This represents a yield of 1%. Smith & Nephew's dividend payout ratio is currently 10,740.74%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.